Arginine vasopressin receptor 2 activation promotes microvascular permeability in sepsis.

Angiopoietin-2 / genetics Animals Antidiuretic Agents / therapeutic use Antidiuretic Hormone Receptor Antagonists / therapeutic use Capillary Permeability / drug effects Cells, Cultured Deamino Arginine Vasopressin / therapeutic use Endothelial Cells / drug effects Female Hemodynamics / drug effects Humans Methicillin-Resistant Staphylococcus aureus Phospholipase C beta / genetics Pneumonia, Staphylococcal / drug therapy Receptors, Vasopressin / agonists Sepsis / drug therapy Sheep Sheep Diseases / drug therapy Tolvaptan / therapeutic use
Endothelium Microvascular hyperpermeability Sepsis Shock Tolvaptan

Journal

Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422

Informations de publication

Date de publication:
01 2021
Historique:
received: 29 04 2020
revised: 23 10 2020
accepted: 27 10 2020
pubmed: 8 11 2020
medline: 19 11 2021
entrez: 7 11 2020
Statut: ppublish

Résumé

Methicillin-resistant Staphylococcus aureus (MRSA) sepsis is a severe condition associated with vascular leakage and poor prognosis. The hemodynamic management of sepsis targets hypotension, but there is no specific treatment available for vascular leakage. Arginine vasopressin (AVP) has been used in sepsis to promote vasoconstriction by activating AVP receptor 1 (V

Identifiants

DOI: 10.1016/j.phrs.2020.105272 PMID: 33160069 PMC: PMC8075069
pubmed: 33160069
pii: S1043-6618(20)31580-2
doi: 10.1016/j.phrs.2020.105272
pmc: PMC8075069
mid: NIHMS1695436
pii:
doi:

Substances chimiques

AVPR2 protein, human 0
Angiopoietin-2 0
Antidiuretic Agents 0
Antidiuretic Hormone Receptor Antagonists 0
Receptors, Vasopressin 0
Tolvaptan 21G72T1950
PLCB4 protein, human EC 3.1.4.11
Phospholipase C beta EC 3.1.4.11
Deamino Arginine Vasopressin ENR1LLB0FP

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

105272

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM097480
Pays : United States

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Références

Int J Mol Med. 2007 Nov;20(5):749-61
pubmed: 17912470
Cytokine. 2015 Jun;73(2):213-8
pubmed: 25794660
J Intern Med. 2015 Mar;277(3):277-293
pubmed: 25418337
Curr Opin Anaesthesiol. 2015 Aug;28(4):411-6
pubmed: 26087275
Thorax. 2014 Sep;69(9):819-25
pubmed: 24891325
Crit Care. 2009;13(2):207
pubmed: 19435476
Crit Care Med. 2012 Jun;40(6):1957-60
pubmed: 22488005
Crit Care Med. 2012 Nov;40(11):3034-41
pubmed: 22890252
Intensive Care Med Exp. 2019 Sep 9;7(1):12
pubmed: 31512009
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2827-31
pubmed: 8610126
Cardiovasc Drugs Ther. 2011 Dec;25 Suppl 1:S77-82
pubmed: 22120096
J Thromb Haemost. 2003 Apr;1(4):682-9
pubmed: 12871401
Am J Respir Crit Care Med. 2018 Jul 15;198(2):220-231
pubmed: 29447449
Am J Physiol Heart Circ Physiol. 2012 Nov 15;303(10):H1245-54
pubmed: 22961865
Cardiovasc Drugs Ther. 2011 Dec;25 Suppl 1:S67-76
pubmed: 22120095
Crit Care Med. 2001 Jul;29(7):1303-10
pubmed: 11445675
Crit Care Med. 2016 Jan;44(1):23-31
pubmed: 26496451
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Shock. 2020 Feb;53(2):156-163
pubmed: 31389906
Crit Care Med. 2015 Jul;43(7):e230-40
pubmed: 25855898
Crit Care Med. 2016 Feb;44(2):e89-96
pubmed: 26465218
Methods Enzymol. 2008;443:137-53
pubmed: 18772015
Crit Care Med. 2006 Feb;34(2):344-53
pubmed: 16424713
J Virol. 2007 Apr;81(8):3980-91
pubmed: 17287278
Thromb Haemost. 2007 Feb;97(2):263-71
pubmed: 17264956
Anal Chem. 2008 Aug 1;80(15):6034-7
pubmed: 18578504
Intensive Care Med. 2002 Feb;28(2):108-21
pubmed: 11907653
Lancet. 2010 Oct 16;376(9749):1339-46
pubmed: 20934212
Crit Care Med. 2016 Nov;44(11):2018-2027
pubmed: 27441903
Circ Heart Fail. 2010 May;3(3):412-9
pubmed: 20176717
Am J Physiol Renal Physiol. 2011 Nov;301(5):F1005-13
pubmed: 21816754
Arterioscler Thromb Vasc Biol. 2006 May;26(5):1002-7
pubmed: 16469951
Shock. 2019 Nov;52(5):e92-e99
pubmed: 30499879
Crit Care Med. 2012 Mar;40(3):754-61
pubmed: 21963582
Crit Care Med. 2010 Dec;38(12):2339-44
pubmed: 20838334
Biochem Biophys Res Commun. 2008 Dec 19;377(3):786-91
pubmed: 18951875
Crit Care Med. 2007 May;35(5):1284-9
pubmed: 17414725
Curr Protein Pept Sci. 2013 Dec;14(8):650-7
pubmed: 24384033
Crit Care Med. 2011 Apr;39(4):718-24
pubmed: 21263320
Intensive Care Med. 2009 Sep;35(9):1567-74
pubmed: 19551369
J Clin Med. 2020 Jan 19;9(1):
pubmed: 31963877
Crit Care Med. 2014 Jul;42(7):e525-e533
pubmed: 24674922
Shock. 2008 May;29(5):642-9
pubmed: 17885644
Am J Physiol Heart Circ Physiol. 2003 Apr;284(4):H1095-103
pubmed: 12505871
Expert Rev Anti Infect Ther. 2012 Jun;10(6):701-6
pubmed: 22734959
N Engl J Med. 2008 Feb 28;358(9):877-87
pubmed: 18305265
Breast Cancer Res Treat. 2013 Nov;142(1):9-18
pubmed: 24122393
J Extracell Vesicles. 2014 Sep 18;3:
pubmed: 25317274
J Cardiol. 2012 Dec;60(6):462-9
pubmed: 23068288
J Clin Invest. 2000 Jul;106(1):107-16
pubmed: 10880054
Med Microbiol Immunol. 2013 Dec;202(6):437-52
pubmed: 23989887

Auteurs

Ernesto Lopez (E)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA.

Satoshi Fukuda (S)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA.

Katalin Modis (K)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA; Department of Surgery, University of Texas Medical Branch Galveston, TX, USA.

Osamu Fujiwara (O)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA.

Baigal Enkhtaivan (B)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA.

Raul Trujillo-Abarca (R)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA.

Koji Ihara (K)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA; Department of Plastic and Reconstructive Surgery, Kagoshima City Hospital, Kagoshima, Japan.

Francisco Lima-Lopez (F)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA; Department of Surgery, University of Texas Medical Branch Galveston, TX, USA.

Dannelys Perez-Bello (D)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA.

Csaba Szabo (C)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology, University of Fribourg, Fribourg, Switzerland.

Donald S Prough (DS)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA.

Perenlei Enkhbaatar (P)

Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: peenkhba@utmb.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Protéines angiogéniques › Angiopoïétines › Angiopoïétine-2 › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Eucaryotes › Animaux › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Antidiurétiques › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Antagonistes des récepteurs de l'hormone antidiurétique › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiologiques cardiovasculaires › Perméabilité capillaire › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Cellules › Cellules cultivées › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines de tissu nerveux › Neuropeptides › Vasopressines › Arginine vasopressine › Desmopressine › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Cellules › Cellules épithéliales › Cellules endothéliales › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiologiques cardiovasculaires › Hémodynamique › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Cocci à Gram positif › Staphylococcaceae › Staphylococcus › Staphylococcus aureus › Staphylococcus aureus résistant à la méticilline › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines et peptides de signalisation intracellulaire › Phosphoinositide Phospholipase C › Phospholipase C beta › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie bactérienne › Pneumopathie à staphylocoques › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur hormone hypophysaire › Récepteurs à la vasopressine › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Sepsie › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Artiodactyla › Ruminants › Ovis › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Maladies de l'animal › Maladies des ovins › Arginine vasopressin receptor 2 activation...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Benzazépines › Tolvaptan › Arginine vasopressin receptor 2 activation...